Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach. | Alzheimers Dement (Amst) | 2024 | 38623383 | PubTator, text mining | PubMed |
| Shared and divergent mental health characteristics of ADNP-, CHD8- and DYRK1A-related neurodevelopmental conditions. | J Neurodev Disord | 2024 | 38622540 | PubTator, text mining | PubMed |
| Dyrk1a is required for craniofacial development in Xenopus laevis. | Dev Biol | 2024 | 38621649 | PubTator, text mining | PubMed |
| KAT7/HMGN1 signaling epigenetically induces tyrosine phosphorylation-regulated kinase 1A expression to ameliorate insulin resistance in Alzheimer's disease. | World J Psychiatry | 2024 | 38617985 | PubTator, text mining | PubMed |
| A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis. | Virol J | 2024 | 38581045 | PubTator, text mining | PubMed |
| First-principles study of multifunctional Mn2B3 materials with high hardness and ferromagnetism. | Phys Chem Chem Phys | 2024 | 38576324 | PubTator, text mining | PubMed |
| An in vitro neurogenetics platform for precision disease modeling in the mouse. | Sci Adv | 2024 | 38569042 | PubTator, text mining | PubMed |
| Decoding the Neurodevelopment and Seizure Puzzle: A Pediatric Case of DYRK1A Gene Mutation and Autosomal Dominant Mental Retardation Type 7. | Cureus | 2024 | 38566780 | PubTator, text mining | PubMed |
| Dual-specificity kinase DYRK3 phosphorylates p62 at the Thr-269 residue and promotes melanoma progression. | J Biol Chem | 2024 | 38519031 | PubTator, text mining | PubMed |
| Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases. | RSC Med Chem | 2024 | 38516603 | PubTator, text mining | PubMed |
| Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids. | Commun Biol | 2024 | 38504123 | PubTator, text mining | PubMed |
| Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis. | Int J Surg | 2024 | 38502850 | PubTator, text mining | PubMed |
| Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases. | Eur J Med Chem | 2024 | 38479168 | PubTator, text mining | PubMed |
| Gene Expression Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes? | Int J Mol Sci | 2024 | 38474215 | PubTator, text mining | PubMed |
| Forkhead box O proteins: steering the course of stem cell fate. | Cell Regen | 2024 | 38466341 | PubTator, text mining | PubMed |
| MicroRNA-221-3p inhibits the inflammatory response of keratinocytes by regulating the DYRK1A/STAT3 signaling pathway to promote wound healing in diabetes. | Commun Biol | 2024 | 38461326 | PubTator, text mining | PubMed |
| Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia. | Haematologica | 2024 | 38426275 | PubTator, text mining | PubMed |
| The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma Cells. | Cancers (Basel) | 2024 | 38398225 | PubTator, text mining | PubMed |
| Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T). | Stem Cell Res | 2024 | 38382213 | PubTator, text mining | PubMed |
| Endothelium-mediated regulation of platelet activation: Involvement of multiple protein kinases. | FASEB J | 2024 | 38334433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=13